Table 4.
Event Rates for Major Clinical Outcomes
| GD Group (N=3056) | NGD Group (N=2920) | Hazard Ratio | P Value | |
|---|---|---|---|---|
| Death | 411 (13.5%) | 374 (12.7%) | 1.05 | 0.417 |
| 1‐year death rate | 2.3% | 2.9% | 0.79 | 0.376 |
| First AF recurrence | 1463 (47.9%) | 1414 (48.4%) | 0.99 | 0.670 |
| 1‐year AF recur rate | 23.6% | 25.1% | 0.94 | 0.005 |
| Stroke | 120 (3.9%) | 108 (3.7%) | 1.05 | 0.645 |
| 1‐year stroke rate | 0.9% | 1.0% | 0.90 | 0.759 |
| 1st cardiac admission | 1224 (40.5%) | 1115 (38.2%) | 1.05 | 0.139 |
| 1‐year cardiac admission rate | 17.4% | 17.5% | 0.99 | 0.351 |
| 1st AF admission | 756 (24.7%) | 726 (24.9%) | 0.99 | 0.911 |
| 1‐year AF admission rate | 10.9% | 11.3% | 0.96 | 0.083 |
| 1st CHF admission | 302 (9.9%) | 249 (8.5%) | 1.16 | 0.070 |
| 1‐year CHF admission rate | 4.00% | 3.00% | 1.33 | 0.428 |
| AF‐related procedures | ||||
| Electrical cardioversion | 427 (14.0%) | 436 (14.9%) | 0.94 | 0.292 |
| AF ablation | 315 (10.3%) | 273 (9.4%) | 1.10 | 0.214 |
| Pacemaker implantation | 233 (7.6%) | 280 (9.6%) | 0.79 | 0.007 |
| AV nodal ablation | 153 (5.0%) | 176 (6.0%) | 0.83 | 0.084 |
| Maze surgery | 60 (2.0%) | 66 (2.3%) | 0.87 | 0.424 |
AF indicates atrial fibrillation; AV, atrioventricular; CHF, congestive heart failure; GD, guideline‐directed group; NGD, non–guideline directed group.